Ghostface is making a surprisingly quick exit from the multiplex. Paramount Pictures has officially moved the latest installment in its flagship horror series, Scream 7, to premium video-on-demand (PVOD) platforms after a theatrical run lasting just over 30 days. This rapid shift to home viewing comes even as the film continues to play in over 2,500 theaters nationwide, sparking debate about the studio's release strategy for one of its most valuable properties.

A Short Run for a Major Franchise

The decision is notable given the film's commercial performance. Scream 7 slashed its way to a $63.6 million domestic opening in late February and has since carved out a global total nearing $205 million. These numbers comfortably push the overall franchise past the $1 billion mark worldwide, cementing its status as a reliable moneymaker for the studio. The film was still generating revenue in cinemas, ranking seventh on the daily box office charts with a six-figure haul, when Paramount pulled the trigger on its digital release.

Read also
Movies
Kristen Stewart's 'Flesh of the Gods' Casts Oscar Nominee Wagner Moura as Co-Star
Kristen Stewart's return to vampire cinema gains major momentum with Oscar nominee Wagner Moura joining the cast of 'Flesh of the Gods,' a new horror project from 'Mandy' director Panos Cosmatos.

This pattern of a truncated exclusive theatrical window is becoming a hallmark of Paramount's approach. Even for successful titles, the studio appears increasingly comfortable accelerating the journey from big screen to living room, a strategy that diverges from many of its competitors who traditionally allow hit films a longer cinematic life. The move suggests a calculated bet on maximizing revenue across all distribution channels in a compressed timeframe.

Critical Reception: A Franchise Running on Fumes?

While the box office tells one story, critical reception paints another. The film arrived burdened by well-publicized behind-the-scenes turmoil, and according to many reviewers, it fails to reinvent the wheel. Our own assessment, echoing sentiments from critics like Collider's Ross Bonaime, finds Scream 7 leaning heavily on nostalgia and familiar tropes without delivering the sharp, meta-commentary that originally defined the series.

"The film ultimately feels like a franchise going through the motions," the review suggests. "Instead of a clever deconstruction of horror clichés, it has become what it once mocked—a standard slasher sequel where the killer's reveal and motive inspire more eye-rolls than screams." For fans wondering if the series still has sharp edges, the consensus indicates the blade may have grown dull.

The Bigger Picture for Paramount and Horror

Paramount's strategy raises questions about the evolving lifecycle of a modern studio tentpole. Is a one-month window sufficient for a film that opened so strongly? The studio seems to believe the ancillary market—digital sales and rentals—is ripe for harvesting sooner rather than later. This could be a savvy play for quick cash or a sign of shifting priorities in how audiences consume major releases.

For horror aficionados looking for something fresh after Scream 7, the landscape offers alternatives. You can explore our list of flawless horror films lost to time or check out how Kaitlyn Dever's 'No One Will Save You' redefines alien horror. Meanwhile, Paramount+ continues to shuffle its library, with titles like James Cameron's 'Terminator' trilogy arriving this April and Oscar Isaac's 'Annihilation' exiting in May.

Scream 7 is now available for digital purchase and rental. Whether its quick pivot to home viewing is a one-off experiment or the new normal for Paramount's hit machines remains a mystery worthy of Ghostface himself.